Navigation Links
Researchers develop flood-tolerant California rice
Post Your Comments:
(Date:11/23/2009)...ng of recent discoveries about the multiple health...s multi-purpose nutrient, increased awareness of t... spurred research and even led to an appreciation ...ing from the health of your immune system to preve...nfluenza, vitamin D is now seen as one of the most...
(Date:11/23/2009)...of General Medical Sciences (NIGMS), part of the N...42.3 million for grants in scientific areas it ide...ed the GO grant program to stimulate biomedical re... American Recovery and Reinvestment Act (Recovery ...e to have a significant impact on a field of biome...
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
Breaking Biology News(10 mins):Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research reveals exactly how coughing is triggered by environmental irritants 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 1Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 2Life Science Firms are Turning to Firmex to do Deals Online 14161 1Life Science Firms are Turning to Firmex to do Deals Online 14161 2Life Science Firms are Turning to Firmex to do Deals Online 14161 3
... brown algae that cover rocks and cause anglers to...rned into diesel fuel, says a Montana State Univer...uel into their gas tanks yet, but Keith Cooksey sa...ars ago. He feels that way today. , "We would be ...ted," Cooksey said. , Cooksey is one of many U.S....
...s headed by an environmental engineer at Washingt...s to produce a biofuel superior to ethanol. , ...ignocellulosic material, plant biomass parts that ...es, corn fiber and husks, all containing in large ...l is considered to be a better biofuel than ethano...
...so available in French . , A research team led...s Department of Microbiology and Immunology has di... immunoregulatory T-cells that regulate the bodys ...and become lazy over time, leading to the onset of...e diabetic (NOD) mice, which were genetically engi...
Other Biology News:Montana State University researcher finds renewed interest in turning algae into fuel 2Montana State University researcher finds renewed interest in turning algae into fuel 3New techniques create butanol 2Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers 2
(Date:11/19/2009)... 19 Spherix Incorporated...or diabetes therapy, and a provider of technical a...ent, biotechnology and pharmaceutical companies, a...6.3 million registered direct placement to institu... stock and warrants to purchase up to 1,104,348 ad...
(Date:11/19/2009)...ass., Nov. 19 Arlington Medical Re... leading driver of antibiotic selection in nosocom... against gram-positive and gram-negative pathogens...osocomial pneumonia, surveyed European physicians ...ovide appropriate coverage against common pathogen...
(Date:11/19/2009)...ns and recognized refractive and cataract surgery ...ght their fellow surgeons up-to-date on the latest...ct surgery, and ophthalmology in general at the re... (AAO) annual meeting in San Francisco, California...avid Huang, MD, Dr. Randy Epstein, Dr. William Tra...
(Date:11/19/2009)...er 19 AFFiRiS AG will focus its,Al... at an unexpectedly early,stage of development: th...Phase II clinical trial early in 2010. This decisi...on of two Phase I trials with the candidates,AD01 ...he first interim,analysis of the secondary endpoin...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...CAGO, Feb. 27 Morningstar, Inc. (Nasdaq:, MORN )...earch, is holding a,conference call for institutio...al funds, hedge funds, pensions, and endowments. T...ition Targets" and it will be held at 11 a.m. EST,...nover, CFA, Morningstar,s equity strategist for th...
...K, Feb. 27 Immtech Pharmaceuticals, Inc. (NYSE Al...ny has signed a Memorandum of Understanding (MOU) ...nt of a strategic alliance with Beijing Pharmaceut...intention of BPGC to consider a range of collabora...h Immtech. , , BPGC is one of the largest state-o...
...SBANE, Calif., Feb. 26 InterMune, Inc.,(Nasdaq: ...r the fourth quarter,and 12 months ended December ...ourth quarter of 2008 of $32.3 million, or $0.83 p...n, or $0.67 per share, in the fourth quarter of 20...icer and President of InterMune,said, "Fourth quar...
Other Biology Technology:Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST 2Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 2Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 3InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 2InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 3InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 4InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 5InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 6InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 7InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 8InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 9InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 10InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 11InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights 12
Non-Receptor Tyrosine Kinase Sampler Kit from BD Biosciences Pharmingen
Viraffinity 15 from Biotech Support Group
PKA Sampler Kit from BD Biosciences Pharmingen
Rabbit Anti-Mouse BCA1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: